Does TOCILIZUMAB Cause Mobility decreased? 4,403 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 4,403 reports of Mobility decreased have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 4.5% of all adverse event reports for TOCILIZUMAB.
4,403
Reports of Mobility decreased with TOCILIZUMAB
4.5%
of all TOCILIZUMAB reports
1,709
Deaths
2,256
Hospitalizations
How Dangerous Is Mobility decreased From TOCILIZUMAB?
Of the 4,403 reports, 1,709 (38.8%) resulted in death, 2,256 (51.2%) required hospitalization, and 1,795 (40.8%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 4,403 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
PREDNISONE (3,699)
Which TOCILIZUMAB Alternatives Have Lower Mobility decreased Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE